The US Supreme Court has rejected an attempt by Intel to challenge the controversialNHK-Fintiv rule, the latest in a series of denials meted out to tech companies and generic drug makers seeking the same review.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
19 January 2022 The US Supreme Court has rejected bids by Apple and Mylan to overturn the NHK-Fintiv rule, but more challenges to the controversial directive favoured by the US Patent Trial and Appeal Board are likely, say lawyers.
11 May 2022 Intel has been ordered to pay $162 million in prejudgment interest to VLSI Technology on top of $2.1 billion in damages for infringing two patents.
16 September 2022 The award is one of the largest patent damages awards in US history | Intel argues that VLSI Technology presented an ‘unreliable damages model’.